Assurasync Consulting
Assurasync Consulting
  • Home
  • About Us
  • Services
    • Regulatory Affairs
    • Quality Assurance
  • Careers
  • Contact Us
  • Article Series
  • More
    • Home
    • About Us
    • Services
      • Regulatory Affairs
      • Quality Assurance
    • Careers
    • Contact Us
    • Article Series
  • Sign In

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • About Us
  • Services
    • Regulatory Affairs
    • Quality Assurance
  • Careers
  • Contact Us
  • Article Series

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

Regulatory Affairs Services

Drug Products

Natural Health Products

Medical Devices

Drug Establishment License (DEL)

Drug Identification Number (DIN)

New Drug Submission (NDS)

Supplemental New Drug Submission (SNDS)

Abbreviated New Drug Submission (ANDS)

Supplemental Abbreviated New Drug Submission (SANDS)

Notifiable Change Submission (NC)

Prescription to OTC Switch (Rx to OTC)


Medical Devices

Natural Health Products

Medical Devices

 

Medical Device Establishment Licence (MDEL) (required by Health Canada for Class I Medical Devices)

Investigational Testing Authorization (ITA) Applications

Licence Applications for Class II, III, and IV Medical Devices

Licence Amendments for Class II, III or IV (significant changes)

Licence Amendment Fax-back applications (minor changes)

Regulatory Submissions

Post-NOC changes

Natural Health Products

Natural Health Products

Natural Health Products

Site licence

Pre-market analysis and review

Preparation and submission of NHP Applications (Class I, II and III)

Post-approval changes

Copyright © 2025 Assurasync Consulting - All Rights Reserved.

Powered by

  • Home
  • Contact Us
  • Article Series

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept